Cardiovascular Disease
VIDEO: Menopause symptoms may be associated with later health risks
ANAHEIM, Calif. — In this video exclusive, Nanette Santoro, MD, describes paradigm shifts in understanding the menopause transition and its implications for health.
Lung cancer survivors may benefit from screenings for cardiovascular risk, substance abuse
NASHVILLE, Tenn. — Lung cancer survivors had similar or increased frequency of and risk for cardiovascular comorbidities and substance abuse than patients with active lung cancer, according to a presenter at the CHEST Annual Meeting.
Risk for major adverse CV events increases for transgender women after orchiectomy
ANAHEIM, Calif. — Transgender women who undergo a gender-affirming orchiectomy may have an increased risk for major adverse cardiovascular events post-procedure, according to a speaker.
Reduce carbohydrate intake, focus on quality to improve health outcomes in diabetes
BOSTON — Reducing overall carbohydrate intake and eating more non-starchy vegetables and whole foods can help improve health outcomes for people with diabetes, according to a speaker at the Cardiometabolic Health Congress.
Lower household income associated with worse cardiovascular outcomes in sleep apnea
NASHVILLE, Tenn. — Patients with obstructive sleep apnea and lower household income had higher odds of acute myocardial infarction, all-cause mortality and cardiac arrest, according to data presented at the CHEST Annual Meeting.
Aspirin does not reduce CVD events, progression to kidney failure in patients with CKD
Among patients with chronic kidney disease, aspirin use did not correlate with reduced risks for CVD, progression to kidney failure or major bleeding, according to data published in Kidney Medicine.
Patients with IPF who experience in-hospital cardiac arrest face increased mortality rate
NASHVILLE, Tenn. — Idiopathic pulmonary fibrosis appeared associated with increased mortality rates and worse outcomes among in-hospital cardiac arrest survivors, according to study results presented at the CHEST Annual Meeting.
Benefits of gender-affirming HT outweigh risks for most transgender women
The benefits of gender-affirming hormone therapy outweigh the risks for transgender women of all ages as well as those with comorbidities, according to a speaker at the 2022 North American Menopause Society annual meeting.
Gestational diabetes increases risks for CV, cerebrovascular diseases
Women with gestational diabetes have increased risks for overall and specific types of cardiovascular and cerebrovascular diseases, whether or not they go on to develop type 2 diabetes, according to study data published in The BMJ.
VIDEO: Updated USPSTF statin guidelines can help PCPs prevent CVD
In August, the U.S. Preventive Services Task Force released a new recommendation statement on the use of statin therapy for primary prevention of CVD. Like its 2016 guidelines, the USPSTF recommended statins as primary prevention for adults aged 40 to 75 years with at least one CVD risk factor and a 10% or greater 10-year risk for CVD.